|Articles|November 2, 2002
- Pharmaceutical Technology-11-02-2002
- Volume 26
- Issue 11
Major Changes Ahead for FDA
Author(s)Jill Wechsler
FDA is juggling momentous changes, including new leadership and the proposed transfer of oversight for therapeutic biotech drugs.
Advertisement
Articles in this issue
about 23 years ago
Contract Servicesabout 23 years ago
Residual Solvent Analysis in PharmaceuticalsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
3
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
